Treatment of Refractory Melasma in Asians With the Picosecond Alexandrite Laser.

Autor:	Polnikorn N; Kasemrad Hospital Prachacheun Aesthetic Center, Bangkok, Thailand., Tanghetti E; Center for Laser and Dermatology, Sacramento, California.
Jazyk:	angličtina
Zdroj:	Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] [Dermatol Surg] 2020 Dec; Vol. 46 (12), pp. 1651-1656.
DOI:	10.1097/DSS.0000000000002612
Abstrakt:	Background/objectives: The picosecond Alexandrite laser was studied in our practice with the diffractive lens array and the flat optic to treat melasma. Methods and Materials: Sixty patients with melasma were treated in a prospective investigation with the picosecond Alexandrite laser. Nineteen patients were treated with the flat optic and 41 patients were treated with the diffractive lens array. Treatments were performed with 1 pass at 2-week intervals for 6 treatments. The Melasma Severity Index (MSI) was used to evaluate the patients before treatment and 3 and 6 months after the final treatment session. Results: At 6 months after the last treatment, there was an 18.5% difference between the groups with a 75.7% improvement in the MSI in patients with the diffractive lens array and a 57.2% improvement in the MSI score in patients with the flat optic. At 6 months, there was recurrence of melasma in 5% of the cases with no hyperpigmentation with the diffractive optic in contrast to recurrence in 16% of the cases in the flat optic group and a transient macular hyperpigmentation in 21% of the cases. Conclusion: This investigation highlights the utility of a picosecond Alexandrite laser with a flat and diffractive lens to successfully treat a large percentage of Asian patients in a sunny climate.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu